论文部分内容阅读
目的观察美托洛尔缓释片治疗原发性高血压并射血分数保留型心力衰竭的疗效。方法选取本院2015年9月至2016年9月收治的74例原发性高血压并射血分数保留型心力衰竭患者作为观察对象,按照不同治疗方法分为参照组(给予左旋氨氯地平治疗)和研究组(给予美托洛尔缓释片治疗)各37例,比较2组各检测指标改善情况及治疗效果。结果研究组SBP、DBP、HR以及E/A、LVDd、LVEF等与参照组比较,组间差异存在统计学意义(t分别=5.0748、4.1806、3.8914、6.7929、3.2844,P均<0.05);研究组的患者治疗总有效率高于参照组患者,其差异有统计学意义(χ2=6.7729,P<0.01)。结论美托洛尔缓释片治疗原发性高血压并射血分数保留型心力衰竭可提高治疗效果,改善病症,提升心功能,值得临床采纳和积极推广。
Objective To observe the curative effect of metoprolol sustained-release tablets in the treatment of essential hypertension and ejection fractional retention heart failure. Methods Seventy-four patients with essential hypertension and preserved ejection fractional heart failure who were treated in our hospital from September 2015 to September 2016 were selected as the observation subjects and divided into the reference group according to different treatment methods (levamlodipine treatment ) And study group (metoprolol sustained release tablets treatment) in 37 cases, comparing the two groups of test indicators to improve the situation and treatment. Results The SBP, DBP, HR, E / A, LVDd and LVEF in the study group were significantly different from those in the reference group (t = 5.0748, 4.1806, 3.8914, 6.7929, 3.2844 respectively, P <0.05) The total effective rate of treatment group was higher than that of reference group, the difference was statistically significant (χ2 = 6.7729, P <0.01). Conclusion Metoprolol sustained release tablets for the treatment of essential hypertension and ejection fractional retention heart failure can improve the therapeutic effect, improve the symptoms and improve the cardiac function, which is worthy of clinical adoption and promotion.